These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 12740485

  • 1. Plaque-stabilizing effect of pitavastatin in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Suzuki H, Kobayashi H, Sato F, Yonemitsu Y, Nakashima Y, Sueishi K.
    J Atheroscler Thromb; 2003; 10(2):109-16. PubMed ID: 12740485
    [Abstract] [Full Text] [Related]

  • 2. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
    Suzuki H, Yamazaki H, Aoki T, Kojima J, Tamaki T, Sato F, Kitahara M, Saito Y.
    Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
    [Abstract] [Full Text] [Related]

  • 3. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Shiomi M, Ito T, Tsukada T, Shiraishi M, Yata T.
    Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
    [Abstract] [Full Text] [Related]

  • 4. Stabilization of atherosclerotic plaque by pitavastatin in Watanabe heritable hyperlipidemic rabbits: A serial tissue-characterizing intravascular ultrasound study.
    Haruta H, Hiro T, Mitsumata M, Takayama T, Sudo M, Li Y, Takahashi R, Taniguchi Y, Shiomi M, Hirayama A.
    J Cardiol; 2016 Feb; 67(2):205-11. PubMed ID: 26194868
    [Abstract] [Full Text] [Related]

  • 5. Pitavastatin inhibits lysophosphatidic acid-induced proliferation and monocyte chemoattractant protein-1 expression in aortic smooth muscle cells by suppressing Rac-1-mediated reactive oxygen species generation.
    Kaneyuki U, Ueda S, Yamagishi S, Kato S, Fujimura T, Shibata R, Hayashida A, Yoshimura J, Kojiro M, Oshima K, Okuda S.
    Vascul Pharmacol; 2007 Apr; 46(4):286-92. PubMed ID: 17178255
    [Abstract] [Full Text] [Related]

  • 6. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
    Kumai T, Oonuma S, Matsumoto N, Takeba Y, Taniguchi R, Kamio K, Miyazu O, Koitabashi Y, Sekine S, Tadokoro M, Kobayashi S.
    Life Sci; 2004 Mar 12; 74(17):2129-42. PubMed ID: 14969717
    [Abstract] [Full Text] [Related]

  • 7. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
    Koike T, Liang J, Wang X, Ichikawa T, Shiomi M, Sun H, Watanabe T, Liu G, Fan J.
    Cardiovasc Res; 2005 Feb 01; 65(2):524-34. PubMed ID: 15639492
    [Abstract] [Full Text] [Related]

  • 8. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Khachadurian AK, Shimamura T, Rozovski SJ, Ananthakrishnan R, Armenian B, Coly E, alHinai A, Martucci C, Schneider SH, Amorosa LF.
    Jpn Heart J; 1991 Sep 01; 32(5):675-85. PubMed ID: 1774829
    [Abstract] [Full Text] [Related]

  • 9. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro.
    Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P.
    Circulation; 2001 Jan 16; 103(2):276-83. PubMed ID: 11208689
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
    Imanishi T, Ikejima H, Tsujioka H, Kuroi A, Kobayashi K, Shiomi M, Muragaki Y, Mochizuki S, Goto M, Yoshida K, Akasaka T.
    Hypertens Res; 2008 Jun 16; 31(6):1199-208. PubMed ID: 18716369
    [Abstract] [Full Text] [Related]

  • 12. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
    Shiomi M, Ito T.
    Br J Pharmacol; 1999 Feb 16; 126(4):961-8. PubMed ID: 10193776
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M, Takeda Y, Mori S, Ishibashi N, Komatsu E, Takahashi K, Fuse T, Yamamura M, Kubo K, Sugiyama Y, Saito Y.
    Br J Pharmacol; 1997 Mar 16; 120(6):1172-8. PubMed ID: 9134232
    [Abstract] [Full Text] [Related]

  • 16. The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe.
    Shiomi M, Ito T.
    Atherosclerosis; 2009 Nov 16; 207(1):1-7. PubMed ID: 19389675
    [Abstract] [Full Text] [Related]

  • 17. Effect of red wine consumption on low-density lipoprotein oxidation and atherosclerosis in aorta and coronary artery in Watanabe heritable hyperlipidemic rabbits.
    Wakabayashi Y.
    J Agric Food Chem; 1999 Nov 16; 47(11):4724-30. PubMed ID: 10552880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits.
    Kato M, Sada T, Mizuno M, Kitayama K, Inaba T, Koike H.
    J Cardiovasc Pharmacol; 2005 Oct 16; 46(4):556-62. PubMed ID: 16160612
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.